Skip to main content
Clinical Trials/NCT04418453
NCT04418453
Completed
Not Applicable

Rural Expansion of Medication Treatment for Opioid Use Disorder (Rural MOUD): Phase 1 Feasibility Study (CTN-0102)

University of California, Los Angeles6 sites in 1 country36,762 target enrollmentJune 1, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Opioid-use Disorder
Sponsor
University of California, Los Angeles
Enrollment
36762
Locations
6
Primary Endpoint
Patient days on MOUD from Electronic Health Records (EHR)
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The feasibility study (Phase 1) will examine the implementation of telemedicine (TM) in six rural clinics in two states/regions with varying levels of OBOT capacity.

Detailed Description

The dramatic increases in opioid overdose deaths across the nation, particularly in rural areas, call for a rapid expansion of access to medication treatment for opioid use disorder (MOUD).There is a need to study effective ways to expand treatment access and improve retention on MOUD in rural areas highly impacted by OUD. Telemedicine (TM) for MOUD offers an alternative or supplementary approach to delivering MOUD that may be suitable for rural clinics and patients with OUD. The objectives of the feasibility study are to study ways of incorporating TM into primary care clinics and to evaluate the associated outcomes, based on EHRs from the clinics and the TM vendor (i.e., patient days on MOUD) and participant surveys (e.g., opioid use). Additional outcomes of the feasibility study are feasibility and acceptability assessed from the perspectives of providers and participants via focus groups. A patient registry will be established in each clinic to track patients with OUD diagnoses, and those in the registry will be provided the opportunity to consent for sharing identified EHRs and participating in the follow-up surveys.

Registry
clinicaltrials.gov
Start Date
June 1, 2020
End Date
November 5, 2021
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Yih-Ing Hser

Principal Investigator

University of California, Los Angeles

Eligibility Criteria

Inclusion Criteria

  • Aged 18-80 years old, inclusive, at the time of the qualifying visit
  • with OUD diagnosis
  • At least 1 visit to the participating clinics from 9 months before and 6 months after the date of intervention implementation

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Patient days on MOUD from Electronic Health Records (EHR)

Time Frame: 9 months

Number of days patients receive MOUD based on EHR data

Secondary Outcomes

  • Number of OUD patients initiating/receiving MOUD(9 months)

Study Sites (6)

Loading locations...

Similar Trials